Tufton Capital Management Reduces Stock Position in Colgate-Palmolive (NYSE:CL)

Tufton Capital Management lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 3.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 26,150 shares of the company’s stock after selling 825 shares during the quarter. Tufton Capital Management’s holdings in Colgate-Palmolive were worth $2,377,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Chicago Partners Investment Group LLC boosted its position in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares during the period. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive in the 4th quarter worth $1,315,000. Gordian Advisors LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $602,000. Carrera Capital Advisors raised its holdings in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC bought a new position in Colgate-Palmolive in the 4th quarter worth $4,066,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. UBS Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Trading Up 0.1 %

Shares of NYSE:CL opened at $90.23 on Friday. The company has a market cap of $73.22 billion, a P/E ratio of 25.63, a PEG ratio of 4.20 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The stock’s fifty day moving average price is $88.75 and its 200-day moving average price is $95.58.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. Sell-side analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.